News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | US Plans to Implement 15% Global Tariffs This Week; Trump Nominates Walsh as Fed Chair; BlackRock Continues to Increase Bitcoin Holdings Recently (March 05, 2026)2Broadcom FY2026 Q1 Earnings: AI Revenue Doubles, Record Results, Strong Guidance, $10B Buyback3Broadcom CEO Predicts AI Chip Revenue Will Surpass $100 Billion by 2027
Capital One Bets $35 Billion: Unveiling the Layoff Surge and True Market Leaders
101 finance·2026/03/05 20:40
Solv Protocol says exploit drained $2.7 million from Bitcoin yield vault
The Block·2026/03/05 20:33
Stocks fall while oil prices rise after Iran warns it may respond to ground offensive
101 finance·2026/03/05 20:27
AI Chip Export Regulations: An Overview of Nvidia, AMD, and Cryptocurrency Trends
101 finance·2026/03/05 20:21
NFLX on March 5: Upside After Deal Call-Off or Trap?
101 finance·2026/03/05 20:09
Meta’s Drop on March 5: Examining Loss Aversion and Herd Mentality from a Behavioral Perspective
101 finance·2026/03/05 20:09
Meta's Drop on March 5: Examining Loss Aversion and Herd Mentality
101 finance·2026/03/05 20:09
A community bank board member resigns, leaving with sharp criticism
101 finance·2026/03/05 20:06
Dogecoin volume jumps 60% – But DOGE can reclaim $0.10 ONLY IF…
AMBCrypto·2026/03/05 20:03
Flash
20:36
U.S. federal banking regulators clarify capital treatment rules for tokenized securitiesThe U.S. federal banking regulators jointly issued a FAQ clarifying the capital treatment rules for tokenized securities. Tokenized securities refer to securities whose ownership is represented using distributed ledger technology. The FAQ states that eligible tokenized securities generally receive the same capital treatment under capital rules as their non-tokenized counterparts. Regulators emphasize that capital rules remain technologically neutral, and the technology used for issuing and trading securities usually does not affect capital treatment. Banks holding tokenized securities must follow risk management practices and comply with relevant laws and regulations.
20:02
Tevogen Bio Holdings (Tevogen) has recently taken a key step in its generic drug business strategy, signing a letter of intent to officially begin evaluating the potential acquisition of Apozeal Pharmaceuticals.This move marks Tevogen's accelerated expansion of its generic drug product line to strengthen its market competitiveness in the biopharmaceutical sector. Through this strategic assessment, Tevogen is expected to further integrate industry resources and increase its share in the global generic drug market.
20:01
Tevogen Bio Holdings Inc is currently actively evaluating other transaction opportunities and has strategically focused its priorities on businesses related to the life sciences sector.The company's move aims to further expand its influence in the biotechnology industry and explore potential opportunities for synergistic growth.
News